Ascendis Pharma A/S
SWB:A71
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ascendis Pharma A/S
SWB:A71
|
DK |
|
Orell Fuessli AG
SIX:OFN
|
CH |
|
B
|
Build-A-Bear Workshop Inc
F:FPW
|
US |
|
Ellington Financial Inc
NYSE:EFC
|
US |
|
Budweiser Brewing Company APAC Ltd
F:4BB1
|
HK |
|
R
|
Ratch Group PCL
SET:RATCH
|
TH |
|
Crescent Biopharma Inc
F:C68
|
US |
Wall St Price Targets
A71 Price Targets Summary
Ascendis Pharma A/S
According to Wall Street analysts, the average 1-year price target for A71 is 262.81 EUR with a low forecast of 222.38 EUR and a high forecast of 320.59 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is A71's stock price target?
Price Target
262.81
EUR
According to Wall Street analysts, the average 1-year price target for A71 is 262.81 EUR with a low forecast of 222.38 EUR and a high forecast of 320.59 EUR.
What is the Revenue forecast for Ascendis Pharma A/S?
Projected CAGR
24%
Over the last 12 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 24%.
What is the Gross Profit forecast for Ascendis Pharma A/S?
Projected CAGR
25%
The compound annual growth rate for Gross Profit over the next 8 years is 25%.
